Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

885 public trials 210 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Terminated

A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

NCT04374136

Conditions
Brain Diseases, Central Nervous System Diseases, Dementia, +10 more
Locations
  • Dignity Health Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
View all 44 locations
View Trial Details
Terminated

A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT06441682

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • UZ Leuven Leuven, Belgium
  • Kaye Edmonton Clinic Edmonton, Canada
  • Montreal Neurological Institute and Hospital Montreal, Canada
  • Aarhus Universitets Hospital Aarhus, Denmark
View Trial Details
Terminated

Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)

NCT05683860

Conditions
Amyotrophic Lateral Sclerosis, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Erasmus MC Rotterdam, Netherlands
  • Universitair Medisch Centrum Utrecht Utrecht, Netherlands
  • University of Oxford - Nuffield Department of Clinical Neurosciences Oxford, United Kingdom
View Trial Details

Related conditions